FDA approaches Nanavati hospital for promoting unapproved “M
The Mumbai-based Nanavati Hospital has sparked controversy upon its recently released video that promotes an unapproved drug for Parkinson’s disease. The Video which saw severe backlash from many in the medical fraternity is now also drawn the attention of the Mumbai Food and Drug Administration (FDA) which has launched an investigation into a video.

In the video, a patient is injected with the drug apomorphine. Soon after, the patient is shown walking, jogging and doing push ups. It also features the Indian cricket team’s former physiotherapist, Ali Irani, recommending the drug.

Maharashtra’s FDA has asked Nanavati Hospital to clarify if they are carrying out clinical trials for apomorphine and if they have permission, according to a report in Mumbai Mirror. The FDA is also reviewing this video in case it is actually a promotion of this drug, which could be a violation of the Drugs and Cosmetics Act, 1940.

Several doctors have also objected to the video, which shows apomorphine as some sort of miracle drug. The video does not disclose that apomorphine’s effect is only temporary, lasting for just an hour or so, after which the patient continues to have either tremors or stiffness.

Know more: https://thewire.in/health/nanavati-hospital-under-scanner-unapproved-parkinsons-drug
A●●●●h M●●u and 2 other likes this3 shares
Like
Comment
Share
Dr. N●●●●a G●●●a
Dr. N●●●●a G●●●a Obstetrics and Gynaecology
Research and trials needs authentication.The ad world is an illusionary world based on partial truth,should not blind the doctors as its risky in both long term and short term
Mar 17, 2019Like1